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908Limited survival in dialysis patients undergoing
intact abdominal aortic aneurysm repair
Theodore H. Yuo, MD, MSc, Joseph Sidaoui, MD, Luke K. Marone, MD, Efthymios D. Avgerinos, MD,
Michel S. Makaroun, MD, and Rabih A. Chaer, MD, MSc, Pittsburgh, Pa
Objective: Elective abdominal aortic aneurysm (AAA) repair in suitable candidates is a standard modality. The outcomes of
AAA repair in patients with end-stage renal disease on dialysis are not well characterized, and there is questionable
survival advantage in such patients with limited life expectancy. We sought to describe outcomes after AAA repair in U.S.
dialysis patients.
Methods: The United States Renal Data System was used to collect data on intact asymptomatic AAA repair procedures in
dialysis patients in the United States between 2005 and 2008. Endovascular AAA repair (EVAR) and open aortic repair
(OAR) were identiﬁed by Current Procedural Terminology codes. Primary outcomes were perioperative (30-day) mor-
tality and long-term survival. Predictors of mortality were identiﬁed by multivariate regression models.
Results: A total of 1557 patients were identiﬁed who had undergone elective AAA repair: 261 OAR and 1296 EVAR. The
30-day mortality was 11.3% (EVAR, 10.3%; OAR, 16.1%; P [ .010), with increased age associated with increased
mortality (odds ratio, 1.04; 95% conﬁdence interval [CI], 1.02-1.07; P [ .001). Kaplan-Meier survival estimates were
66.5% at 1 year (EVAR, 66.2%; OAR, 68%) and 37.4% at 3 years (EVAR, 36.8%; OAR, 40%; P[ .33). Median survival
was 25.3 months after EVAR and 27.4 months after OAR. Women had a higher mortality rate at 1 year (38.7%)
compared with men (32.0%) (P [ .015). There was no signiﬁcant mortality difference at 1 year in comparing type of
procedure in both men (EVAR, 31.6%; OAR, 34%; P [ .55) and women (EVAR, 39.3%; OAR, 36%; P [ .60). A Cox
proportional hazards model demonstrated that male gender (hazard ratio [HR], 0.75; 95% CI, 0.62-0.92; P [ .005),
increased time on dialysis (HR for each year on dialysis, 0.79; 95% CI, 0.75-0.83; P < .001), kidney transplantation
history (HR, 0.62; 95% CI, 0.43-0.88; P [ .008), and diagnosis of hypertension (HR, 0.60; 95% CI, 0.48-0.75;
P < .001) were protective against mortality. Increased age (HR, 1.02; 95% CI, 1.01-1.03; P < .001) and diabetes
diagnosis (HR, 1.39; 95% CI, 1.13-1.71; P [ .002) predicted increased mortality.
Conclusions: AAA patients on dialysis have high perioperative and 1-year mortality rates after EVAR or OAR, particularly
diabetics, women, and the elderly. This raises questions about the indications for intact AAA repair in dialysis patients, in
whom the size threshold may need to be raised. Dialysis patients may be best served by deferring repair of AAA until
AAAs reach large size or become symptomatic, especially if OAR is required, given the higher perioperative mortality
compared with EVAR. (J Vasc Surg 2014;60:908-13.)Abdominal aortic aneurysm (AAA) is a signiﬁcant cause
of mortality in older persons, representing the 15th leading
cause of death overall and the 10th leading cause in men
older than 55 years in the United States.1 When AAAs are
symptomatic, repair is associated with poor survival rates.2
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://dx.doi.org/10.1016/j.jvs.2014.04.050diameter, typically 5.5 cm, prophylactic repair is advocated
by multiple specialty society guidelines to prevent rupture
and death.3,4 However, in patients with multiple medical
comorbidities who were not eligible for open surgical repair,
endovascular repair of AAA has not been shown to provide
an all-cause survival beneﬁt.5 This has led some authors to
suggest that patients with overall poor life expectancy and
those who cannot safely tolerate a minimally invasive proce-
dure should not undergo AAA repair, although the preoper-
ative identiﬁcation of these patients can be difﬁcult.1,6
Patients with end-stage renal disease (ESRD) requiring
dialysis as renal replacement therapy are known to have
elevated baseline mortality compared with age-matched
patients without ESRD.7 As a result, the question arises
whether this patient population represents a suitable group
for elective AAA repair. Therefore, we sought to charac-
terize contemporary perioperative and long-term outcomes
of intact AAA repair in patients with ESRD in the United
States to determine if current intervention guidelines are
justiﬁed in these patients with limited life expectancy.
METHODS
Data source. After local Institutional Review Board
approval, we obtained de-identiﬁed patient-speciﬁc data
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standard analytic ﬁles from 2005 to 2008. This database
has been designed to be an integrated and consistent
resource for investigating health outcomes for patients with
ESRD.8 Available data include information on treatment
history, hospitalization events, and physician and supplier
services. Physician services are encoded with Current
Procedural Terminology (CPT) codes, which are accom-
panied by International Classiﬁcation of Diseases, Ninth
Revision, Clinical Modiﬁcation (ICD-9-CM) diagnosis
codes.We collected data on intact asymptomatic AAA repair
for ESRD patients receiving dialysis as renal replacement
therapy. Explicit patient consent was not obtained, pursuant
to CMS rules allowing for release of limited data sets with a
Data Use Agreement executed with the USRDS Coordi-
nating Center (see U.S. Department of Health & Human
Services [2003 April 3] “OCR HIPAA Privacy, Research.”
Retrieved from http://www.hhs.gov/ocr/privacy/hipaa/
understanding/coveredentities/research.html).
Patients. We selected patients who underwent open or
endovascular repair for infrarenal AAA. During the study
period, endovascular aneurysm repair (EVAR) was not
the mainstream approach in clinical practice for ruptured
AAA in the United States. Because of that and limitations
of the CPT codes, we implicitly assumed that all patients
who underwent EVAR had intact aneurysms. We tested
this assumption by evaluating whether the ICD-9 code
for ruptured AAA (441.3) was associated with the CPT
code for EVAR and found that 6.6% of the EVAR popu-
lation was potentially misclassiﬁed. We excluded patients
younger than 30 years at the time of the aortic repair.
Patients with ruptured or mycotic AAA were excluded, as
were patients requiring visceral vessel reconstruction. Pa-
tients with symptomatic but unruptured AAA were com-
bined with asymptomatic aneurysms in our analysis because
of their implied hemodynamic stability. Demographics,
comorbidities, and risk factors are outline in Table I.
The primary outcomes of our study were perioperative
(30-day) mortality and long-term survival. Secondary out-
comes were perioperative complications, which included
sepsis, ileus, need for mechanical ventilation, erectile
dysfunction, shock, stroke, amputation, incisional hernia
repair, myocardial infarction, stroke, tracheostomy, and
repeated AAA repair, which were determined by the use
of CPT codes and ICD-9 diagnosis codes. The 30-day
period deﬁning the perioperative window was determined
on the basis of the date of service speciﬁed in the claims
database.
In a separate analysis, we used the ICD-9 diagnosis
code for intact AAA (441.4) to identify patients who car-
ried the diagnosis of AAA at the time of ESRD declaration
to determine its relationship to survival.
Deﬁnitions. Using CPT codes, we separated AAA
repair procedures into open aortic repair (OAR) and
EVAR. Open AAA repair for ruptured aneurysms calls for
different CPT codes and was not included in the analysis.
OAR after unsuccessful EVAR was deﬁned as OAR
(Supplementary Table, online only).Statistical analysis. We used c2 statistics to test differ-
ences between procedures and genders with respect to the
incidence of death. Logistic regression models tested the
effect of comorbidities and demographic characteristics
on the incidence of death at 30 days. These included fac-
tors commonly associated with increased perioperative
risk, including the presence of coronary disease, obstructive
lung disease, age, and gender. Kaplan-Meier survival esti-
mates were calculated for EVAR and OAR and also for
each gender. Differences in survival between patients who
underwent EVAR vs OAR and genders were assessed by a
log-rank test.9 Multivariate Cox proportional hazards
models were constructed to identify preoperative risk fac-
tors for mortality. Final models were selected by stepwise
forward progression. We also examined the survival of
ESRD patients who carried the diagnosis of AAA and those
who did not have the AAA diagnosis with Kaplan-Meier
survival estimates and compared them by the log-rank
test. Results were considered statistically signiﬁcant when
P < .05.
RESULTS
Demographics and comorbidities. A total of 4366
patients carried a diagnosis of unruptured AAA at the
time of dialysis initiation, and 1557 patients underwent
asymptomatic AAA repair as identiﬁed in the USRDS stan-
dard analytic ﬁles, which spanned 2005 to 2008. This
included 261 patients (16.8%) who underwent OAR and
1296 (83.2%) who underwent EVAR. There was no statis-
tically signiﬁcant difference between the two groups with
respect to age and sex of the patients. Hemodialysis was
the most used dialysis method for both groups. In terms
of other comorbidities, none was statistically signiﬁcantly
different between the EVAR and OAR patients (Table I).
Outcomes
Perioperative mortality results. In univariate anal-
ysis, the perioperative (30-day) mortality rate was 11.3%
for the entire cohort, but it was signiﬁcantly lower after
EVAR compared with OAR (10.3% vs 16.1%; P ¼ .010).
In our ﬁnal multivariate logistic regression, EVAR was
associated with a nonsigniﬁcant reduction in mortality at
30 days (odds ratio [OR], 0.67; 95% conﬁdence interval
[CI], 0.40-1.11; P ¼ .122). Increased mortality at 30 days
was associated with older age at the time of operation
(OR for each additional year, 1.04; 95% CI, 1.02-1.07;
P ¼ .001). Conversely, lower mortality was associated with
more time on dialysis (OR for each year on dialysis, 0.81;
95% CI, 0.73-0.90; P < .001), diagnosis of hypertension
(OR, 0.53; 95% CI, 0.32-0.88; P ¼ .013), and increased
body mass index (BMI; OR for each additional unit, 0.93;
95% CI, 0.89-0.98; P ¼ .002).
Perioperative complications. OAR was associated
with higher rates of ileus and pneumonia compared with
EVAR. In addition, of the patients who underwent OAR,
less than 4% had an incisional hernia during the ﬁrst month
after the procedure (Table II). Of the patients who
underwent EVAR, 0.9% of patients subsequently
Table I. Demographics, comorbidities, and risk factors by type of procedure
OAR (n ¼ 261), No. (%) EVAR (n ¼ 1296), No. (%) P value
Age, years, mean (SD) 64.9 (10.1) 65.0 (10.5) .901
Gender, male/female 188 (72)/73 (28) 963 (74.3)/333 (25.7) .441
Hemodialysis/peritoneal dialysis 222 (95)/13 (6) 1091 (92.7)/86 (7.3) .401
Diabetes 41 (26) 201 (25.2) .921
History of transplantation 42 (16) 260 (20.1) .15
Ischemic heart disease 53 (33) 275 (34.4) .785
Cerebrovascular disease 17 (11) 84 (10.5) 1.000
Peripheral vascular disease 24 (15) 165 (20.6) .127
Hypertension 128 (80) 655 (81.9) .577
Current tobacco use 16 (10) 71 (8.9) .651
Presence of neoplasm <11 (<4) 39 (4.9) .135
Time on dialysis, years, mean (SD) 4.2 (2.5) 4.5 (3.0) .220
BMI, mean (SD) 25.9 (5.9) 26.6 (5.9) .107
BMI, Body mass index; EVAR, endovascular aneurysm repair; OAR, open aortic repair; SD, standard deviation.
Because of missing data, numbers vary among rows. To comply with Centers for Medicare and Medicaid Services privacy rules, cell sizes less than 11 are
masked.
Table II. Perioperative (30-day) complications after
open aortic repair (OAR) and endovascular aneurysm
repair (EVAR) in patients on dialysis
OAR
(n ¼ 261)
EVAR
(n ¼ 1296) P
value
No. % No. %
Sepsis 16 6 62 4.8 NS
Ileus 14 5 34 2.6 .019
Erectile dysfunction <11 <4 <11 <0.8 NS
Pneumonia 43 17 117 9.0 <.001
Shock <11 <4 <11 <0.8 NS
Stroke <11 <4 70 5.4 NS
Incisional hernia <11 <4 NA NA
Myocardial infarction 21 8 82 6.3 NS
Amputation <11 <4 38 2.9 NS
Open after unsuccessful
EVAR
NA <11 0.8 NA
NA, Not applicable; NS, not signiﬁcant.
To comply with Centers for Medicare and Medicaid Services privacy rules,
cell sizes less than 11 are masked.
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as deﬁned by the CPT code used.
Medium and long-term results. Kaplan-Meier esti-
mates of survival were 66.5% at 1 year (EVAR, 66.2%;
OAR, 68%) and 37.4% at 3 years (EVAR, 36.8%; OAR,
40%) and were not statistically different between procedure
types (P ¼ .33) (Fig). Median survival was 25.3 months
after EVAR and 27.4 months after OAR.
Women had a higher overall mortality rate at 1 year
(38.7%) compared with men (32.0%) (P ¼ .015). There
was no signiﬁcant mortality difference at 1 year in
comparing type of procedure in both men (EVAR,
31.6%; OAR, 34.0%; P ¼ .55) and women (EVAR,
39.3%; OAR, 35.6%; P ¼ .60).
In contrast to the perioperative results, Cox propor-
tional hazards models across the follow-up period demon-
strated increased risk of mortality with EVAR, but this wasnot statistically signiﬁcant (hazard ratio [HR], 1.27; 95%
CI, 0.499-1.63; P ¼ .059). The ﬁnal model found
increased age (HR for each additional year of age, 1.02;
95% CI, 1.01-1.03; P < .001) and diagnosis of diabetes
(HR, 1.39; 95% CI, 1.13-1.71; P ¼ .002) to be indepen-
dent predictors of mortality. Diagnosed cardiac disease
was also associated with increased mortality but was of
borderline statistical signiﬁcance (HR, 1.31; 95% CI,
1.00-1.71; P ¼ .051). Protective factors included male
gender (HR, 0.75; 95% CI, 0.62-0.92; P ¼ .005), white
race (HR, 0.79; 95% CI, 0.64-0.97; P ¼ .027), increased
time on dialysis (HR for each year on dialysis, 0.79; 95%
CI, 0.75-0.83; P < .001), history of kidney transplantation
(HR, 0.62; 95% CI, 0.43-0.88; P ¼ .008), diagnosis of
hypertension (HR, 0.60; 95% CI, 0.48-0.75; P < .001),
and increased BMI (HR for each additional unit, 0.98;
95% CI, 0.96-0.99; P ¼ .021).
Comparison of survival between patients with and
without AAA diagnosis. The diagnosis of AAA, regard-
less of whether it was associated with an operative repair
code, was also associated with increased mortality among
patients on dialysis. Kaplan-Meier estimates of survival for
patients without AAA were 76.0% at 1 year and 41.9% at
3 years. In comparison, for the group with AAA, survival
was 57.4% at 1 year and 23.1% at 3 years. This was statis-
tically signiﬁcant overall (P < .001).DISCUSSION
Our most important ﬁnding is the high absolute mor-
tality rate for patients on dialysis undergoing AAA repair,
regardless of whether the patient underwent EVAR or
OAR. In our analysis, dialysis patients who underwent
EVAR had a perioperative mortality rate of 10.3%, whereas
those who underwent OAR had a mortality rate of 16.1%.
These ﬁgures are much higher than the published experi-
ence of patients in the general population, which suggest
contemporary perioperative mortality rates ranging from
1.1% to 4.8% after OAR and 0% to 1.2% after EVAR.10-13
Fig. Three-year Kaplan-Meier survival estimates for patients
undergoing endovascular aneurysm repair (EVAR) and open
aortic repair (OAR). Standard error is less than 10% at all time
points.
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OAR in the general population, we found that the initial
survival advantage of patients undergoing EVAR compared
with OAR disappeared at 1 year, with similar survival at
3 years.11,14 However, absolute mortality is higher in our
analysis, with a 1-year mortality rate of approximately one
third regardless of the type of AAA repair performed,
compared with published registry data, which reported
1-year mortality rates of 5.8% for OAR and 5.7% for EVAR.15
Interestingly, merely carrying the diagnosis of AAA is
also associated with poor outcomes in this population,
with 1-year mortality of approximately 40% and 3-year
mortality exceeding 75%. Although it is difﬁcult to
compare the outcomes of dialysis patients with repaired
and unrepaired AAA, given the lack of AAA-related
anatomic and clinical details in the USRDS, the survival
of dialysis patients who carry the diagnosis of AAA is
poor and may not be improved by AAA repair.
Also consistent with previous published reports of
unselected patients, we found that men experienced lower
mortality rates compared with women in the ﬁrst year after
aortic repair.16 Multivariate analyses revealed that mortality
is associated with older age, less time on dialysis, absence of
a transplant, higher BMI, and absence of hypertension.
The association of improved survival with higher BMI
echoes the “obesity paradox” found in other survival
models after vascular surgery.17,18 The association of hy-
pertension with improved survival is counterintuitive but
has been described before, and it may be related to better
care in patients with that diagnosis.19 Other researchers
have demonstrated that mortality among the general
ESRD population is highest soon after initiation of dialysis
and then drops off with increasing time after initiation,
which is consistent with our ﬁnding that increased time
on dialysis is associated with improved perioperative and
long-term survival.20,21 The ESRD population undergoing
AAA repair appears to have a high proportion of patientswith diabetes, with approximately 25% of the population
carrying that diagnosis, which is higher than reports of un-
selected patients, in which the incidence is below 5%.22
Finally, we noted higher rates of postoperative complica-
tions including ileus and pneumonia (Table II) after
OAR compared with EVAR, similar to AAA patients
without ESRD.23-25 Fewer than 11 patients, representing
less than 0.8% of the EVAR population, required conver-
sion to open repair, suggesting that conversion was not a
signiﬁcant cause of mortality in this population.
Current clinical practice guidelines state that patients
with an infrarenal AAA who are likely to live a reasonable
time and who are good-risk surgical candidates can beneﬁt
from open or endovascular intervention.3,26,27 However,
some authors suggest that patients with poor life expec-
tancy or those who cannot safely tolerate a minimally inva-
sive procedure should not be treated with repair and
instead be managed medically.1,6,15 Others have suggested
that patients with severe renal dysfunction should have a
higher threshold for AAA repair.23,28 The deﬁnition of
what constitutes poor life expectancy is controversial;
some authors focus on 1 year, whereas existing guidelines
from some specialty societies articulate a 2-year or 3-year
ﬁgure.3,15,26,27 For comparison, our results suggest that
the median survival in dialysis patients is approximately
2 years after both EVAR and OAR, whereas patients
who carried the diagnosis of AAA but did not undergo
repair had a median survival of approximately 17 months.
The contemporary natural history of AAA based on diam-
eter has recently been described, with rupture rates
ranging from 10% per year for 5.5-cm AAA to 20% per
year for AAA larger than 7.0 cm.29 This should be
compared with the 11% perioperative risk of death in
this population and median life expectancy of approxi-
mately 2 years. Given these statistics, it may be appro-
priate to postpone repair in dialysis patients until the
AAA diameter reaches 6 cm.
Our ﬁnding of very high mortality rates for patients on
dialysis after aortic repair has been described before. Other
investigators have constructed prediction models that pre-
dict mortality15,30 after both OAR and EVAR. Renal insuf-
ﬁciency and renal failure requiring dialysis were found to be
strong risk factors for mortality, both in the perioperative
period and in long-term follow-up. These ﬁndings suggest
that most dialysis patients with an intact AAA can be
managed with a nonoperative approach.
Our study has several strengths and limitations that
should be reviewed. First, the comprehensive nature of
the USRDS database gives an opportunity to assess out-
comes for nearly the entire ESRD population in the United
States. Second, patient vital status is closely tracked, giving
conﬁdence in the survival curves. Finally, our analysis did
not ﬁnd signiﬁcant differences in age, comorbidities, and
risk factors between the patients who underwent EVAR
and OAR, suggesting that comparison between the two
groups suffers from a limited level of confounding.
These strengths need to be balanced against several
important limitations. First, as with other retrospective
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variables are unavailable, including medications, size of
the AAA, tortuosity of the access vessels, and operative de-
tails including the types of stent grafts employed. Second,
we are not able to identify a clinically comparable group
of asymptomatic patients with AAA who were managed
conservatively, and as such we cannot determine the natu-
ral history of AAA in this patient population who do not
undergo repair. Of note, it is possible to perform a compar-
ison among patients who carry AAA as a diagnosis based on
ICD-9 codes between those who underwent repair and
those who did not. However, without more detailed infor-
mation about the clinical decision making that led to the
decision not to offer a repair, this would not be a meaning-
ful comparison. Finally, the billing codes we used to iden-
tify procedures are unlikely to be completely accurate and
may not reﬂect the clinical procedure actually performed.
Despite these limitations, we believe that our results
demonstrate that patients on dialysis represent a high-risk
population with limited life expectancy who do not derive
a survival beneﬁt from elective AAA repair.
CONCLUSIONS
The decision to proceed with either EVAR or OAR for
patients on dialysis with intact AAA requires an individual-
ized risk-beneﬁt analysis that includes an assessment of
perioperative risks, long-term beneﬁts, and patient prefer-
ences. Given the high operative mortality combined with
the poor life expectancy of this population of patients, espe-
cially the elderly, women, and those with diabetes, patients
considering elective asymptomatic AAA repair may wish to
defer this treatment unless the risk of rupture is deemed to
be very high because of aneurysm size or another extenu-
ating clinical situation exists.
We wish to recognize the efforts of Larry Fish, PhD,
whose assistance with statistical analysis and data manage-
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Supplementary Table (online only). Endovascular and open abdominal aortic aneurysm (AAA) repair Current
Procedural Terminology (CPT) codes
Endovascular repair
34800 Endovascular repair of infrarenal abdominal aortic aneurysm or dissection; using aorto-aortic tube prosthesis
34802 Endovascular repair of infrarenal abdominal aortic aneurysm or dissection; using modular bifurcated prosthesis (one docking
limb)
34803 Endovascular repair of infrarenal abdominal aortic aneurysm or dissection; using modular bifurcated prosthesis (two docking
limbs)
34804 Endovascular repair of infrarenal abdominal aortic aneurysm or dissection; using unibody bifurcated prosthesis
34805 Endovascular repair of infrarenal abdominal aortic aneurysm or dissection; using aorto-uni-iliac or aorto-unifemoral prosthesis
34812 Open femoral artery exposure for delivery of endovascular prosthesis, by groin incision, unilateral
34820 Open iliac artery exposure for delivery of endovascular prosthesis or iliac occlusion during endovascular therapy, by abdominal
or retroperitoneal incision, unilateral
34825 Placement of proximal or distal extension prosthesis for endovascular repair of infrarenal abdominal aortic or iliac aneurysm,
false aneurysm, or dissection; initial vessel
34833 Open iliac artery exposure with creation of conduit for delivery of aortic or iliac endovascular prosthesis, by abdominal or
retroperitoneal incision, unilateral
34834 Open brachial artery exposure to assist in the deployment of aortic or iliac endovascular prosthesis by arm incision, unilateral
Open repair
34830 Open repair of infrarenal aortic aneurysm or dissection, plus repair of associated arterial trauma, following unsuccessful
endovascular repair; tube prosthesis
34831 Open repair of infrarenal aortic aneurysm or dissection, plus repair of associated arterial trauma, following unsuccessful
endovascular repair; aorto-bi-iliac prosthesis
34832 Open repair of infrarenal aortic aneurysm or dissection, plus repair of associated arterial trauma, following unsuccessful
endovascular repair; aorto-bifemoral prosthesis
35081 Direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for
aneurysm, pseudoaneurysm, and associated occlusive disease, abdominal aorta
35102 Direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for
aneurysm, pseudoaneurysm, and associated occlusive disease, abdominal aorta involving iliac vessels (common, hypogastric,
external)
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